Condition category
Cancer
Date applied
30/09/2005
Date assigned
30/09/2005
Last edited
17/09/2012
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Mr Timothy Philp

ORCID ID

Contact details

Consultant Urologist
WXUHT
London
E11 1NR
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0080056792

Study information

Scientific title

Acronym

Study hypothesis

This study will investigate patient acceptance, quality of life and survival/disease progression free interval in patients with locally advanced or metastatic prostate cancer in remission after six months treatment and disease control with androgen blockade.

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Not Specified

Patient information sheet

Condition

Cancer: Prostate

Intervention

Intermittent vs continuous sex hormone suppression

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Patient acceptance, quality of life and survival/disease progression.

Secondary outcome measures

Not provided at time of registration

Overall trial start date

31/12/1997

Overall trial end date

31/12/2003

Reason abandoned

Eligibility

Participant inclusion criteria

200 patients recruited from Urological Oncology Clinical who have had six months androgen blockade.

Participant type

Patient

Age group

Not Specified

Gender

Male

Target number of participants

200

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

31/12/1997

Recruitment end date

31/12/2003

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Consultant Urologist
London
E11 1NR
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Charity

Funder name

Orchid Cancer Appeal (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2004 results in http://www.ncbi.nlm.nih.gov/pubmed/15331894

Publication citations

  1. Results

    Lane TM, Ansell W, Farrugia D, Wilson P, Williams G, Chinegwundoh F, Philp T, Hines J, Oliver RT, Long-term outcomes in patients with prostate cancer managed with intermittent androgen suppression., Urol. Int., 2004, 73, 2, 117-122, doi: 10.1159/000079690.

Additional files

Editorial Notes